Martin A. Lehr's most recent trade in Context Therapeutics Inc was a trade of 802,700 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Context Therapeutics Inc | Martin A. Lehr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 802,700 | 802,700 | - | - | Stock Option (right to buy) |